{"title":"更正\"黑山初级保健一级心血管疾病或心血管疾病高风险患者双氯芬酸处方模式:回顾性国家药物利用研究\"","authors":"E Editorial","doi":"10.2298/vsp2310892e","DOIUrl":null,"url":null,"abstract":"In the original article titled ?Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: retrospective, national, drug utilization study? published in the September 2023 issue of the Vojnosanitetski Pregled 1, the heading for the third, right-hand column of data in Table 1 should have been given as ?Patients with CVD/risk for CVD on diclofenac therapy, n (%)? instead of ?Patients with CVD on diclofenac therapy, n (%)?. 1. Stankovic M, Turkovic N, Dobric S, Rancic N. Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: retrospective, national, drug utilization study. Vojnosanit Pregl 2023; 80(9): 778-88. (DOI: https://doi.org/10.2298/VSP221229021S) <br><br><font color=\"red\"><b> Link to the corrected article <u><a href=\"http://dx.doi.org/10.2298/VSP221229021S\">10.2298/VSP221229021S</a></b></u>","PeriodicalId":23531,"journal":{"name":"Vojnosanitetski pregled","volume":"119 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum “Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: Retrospective, national, drug utilization study”\",\"authors\":\"E Editorial\",\"doi\":\"10.2298/vsp2310892e\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the original article titled ?Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: retrospective, national, drug utilization study? published in the September 2023 issue of the Vojnosanitetski Pregled 1, the heading for the third, right-hand column of data in Table 1 should have been given as ?Patients with CVD/risk for CVD on diclofenac therapy, n (%)? instead of ?Patients with CVD on diclofenac therapy, n (%)?. 1. Stankovic M, Turkovic N, Dobric S, Rancic N. Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: retrospective, national, drug utilization study. Vojnosanit Pregl 2023; 80(9): 778-88. (DOI: https://doi.org/10.2298/VSP221229021S) <br><br><font color=\\\"red\\\"><b> Link to the corrected article <u><a href=\\\"http://dx.doi.org/10.2298/VSP221229021S\\\">10.2298/VSP221229021S</a></b></u>\",\"PeriodicalId\":23531,\"journal\":{\"name\":\"Vojnosanitetski pregled\",\"volume\":\"119 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vojnosanitetski pregled\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2298/vsp2310892e\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vojnosanitetski pregled","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2298/vsp2310892e","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
原文标题为:黑山初级卫生保健水平的心血管疾病或高危心血管疾病患者双氯芬酸的处方模式:回顾性国家药物使用研究?发表在2023年9月的Vojnosanitetski Pregled 1上，表1中右侧第三列数据的标题应该是:CVD患者/双氯芬酸治疗CVD风险，n (%)?而CVD患者接受双氯芬酸治疗，n (%)?1. Stankovic M, Turkovic N, Dobric S, Rancic N.黑山初级卫生保健水平心血管疾病或高危心血管疾病患者双氯芬酸处方模式:回顾性，国家，药物使用研究。生物工程学报，2023;80(9): 778 - 88。(DOI: https://doi.org/10.2298/VSP221229021S) <br><br><font color="red"><链接到更正后的文章<u><a href="http://dx.doi.org/10.2298/VSP221229021S">10.2298/VSP221229021S</a></b><
Corrigendum “Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: Retrospective, national, drug utilization study”
In the original article titled ?Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: retrospective, national, drug utilization study? published in the September 2023 issue of the Vojnosanitetski Pregled 1, the heading for the third, right-hand column of data in Table 1 should have been given as ?Patients with CVD/risk for CVD on diclofenac therapy, n (%)? instead of ?Patients with CVD on diclofenac therapy, n (%)?. 1. Stankovic M, Turkovic N, Dobric S, Rancic N. Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: retrospective, national, drug utilization study. Vojnosanit Pregl 2023; 80(9): 778-88. (DOI: https://doi.org/10.2298/VSP221229021S)
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
